CycPeptMPDB: A Comprehensive Database of Membrane Permeability of Cyclic Peptides
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Recently, cyclic peptides have been considered breakthrough drugs because they can interact with "undruggable" targets such as intracellular protein-protein interactions. Membrane permeability is an essential indicator of oral bioavailability and intracellular targeting, and the development of membrane-permeable peptides is a bottleneck in cyclic peptide drug discovery. Although many experimental data on membrane permeability of cyclic peptides have been reported, a comprehensive database is not yet available. A comprehensive membrane permeability database is essential for developing computational methods for cyclic peptide drug design. In this study, we constructed CycPeptMPDB, the first web-accessible database of cyclic peptide membrane permeability. We collected information on a total of 7334 cyclic peptides, including the structure and experimentally measured membrane permeability, from 45 published papers and 2 patents from pharmaceutical companies. To unambiguously represent cyclic peptides larger than small molecules, we used the hierarchical editing language for macromolecules notation to generate a uniform sequence representation of peptides. In addition to data storage, CycPeptMPDB provides several supporting functions such as online data visualization, data analysis, and downloading. CycPeptMPDB is expected to be a valuable platform to support membrane permeability research on cyclic peptides. CycPeptMPDB can be freely accessed at http://cycpeptmpdb.com.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Macrocyclic Peptides as Drug Candidates: Recent Progress and Remaining Challenges
Vinogradov, A. A., Yin, Y., & Suga, H. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.8b13178 · Cited by 848
Improving Oral Bioavailability of Peptides by Multiple N‐Methylation: Somatostatin Analogues
Biron, E., Chatterjee, J., Ovadia, O., Langenegger, D., Brueggen, J., Hoyer, D., Schmid, H. A., Jelinek, R., Gilon, C., Hoffman, A., et al. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200705797 · Cited by 374
Utilizing graph machine learning within drug discovery and development
Gaudelet, T., Day, B., Jamasb, A. R., Soman, J., Regep, C., Liu, G., Hayter, J. B. R., Vickers, R., Roberts, C., Tang, J., et al. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab159 · Cited by 313
Drug‐Like Properties in Macrocycles above MW 1000: Backbone Rigidity versus Side‐Chain Lipophilicity
Furukawa, A., Schwochert, J., Pye, C. R., Asano, D., Edmondson, Q. D., Turmon, A. C., Klein, V. G., Ono, S., Okada, O., & Lokey, R. S. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202004550 · Cited by 79
Research works printed but not linked: 25
- Verdine, 2007, The challenge of drugging undruggable targets in cancer: Lessons learned from targeting BCL-2 family members, Clin. Cancer Res., 13, 7264, 10.1158/1078-0432.CCR-07-2184 · DOI · Paper page
- Li, 2022, Plasma protein binding prediction focusing on residue-level features and circularity of cyclic peptides by deep learning, Bioinformatics, 38, 1110, 10.1093/bioinformatics/btab726 · DOI
- Goto, 2021, The RaPID Platform for the Discovery of Pseudo-Natural Macrocyclic Peptides, Acc. Chem. Res., 54, 3604, 10.1021/acs.accounts.1c00391 · DOI · Paper page
- Yamagishi, 2011, Natural product-like macrocyclic N-methyl-peptide inhibitors against a ubiquitin ligase uncovered from a ribosome-expressed de novo library, Chem. Biol., 18, 1562, 10.1016/j.chembiol.2011.09.013 · DOI · Paper page
- Zorzi, 2017, Cyclic peptide therapeutics: past, present and future, Curr. Opin. Chem. Biol., 38, 24, 10.1016/j.cbpa.2017.02.006 · DOI · Paper page
- Hosono, 2023, Amide-to-ester substitution as a stable alternative to N-methylation for increasing membrane permeability in cyclic peptides, Nat. Commun., 10.1038/s41467-023-36978-z · DOI
- Dougherty, 2019, Understanding Cell Penetration of Cyclic Peptides, Chem. Rev., 119, 10241, 10.1021/acs.chemrev.9b00008 · DOI · Paper page
- Whitty, 2016, Quantifying the chameleonic properties of macrocycles and other high-molecular-weight drugs, Drug Discovery Today, 21, 712, 10.1016/j.drudis.2016.02.005 · DOI · Paper page
- Danelius, 2020, Solution Conformations Explain the Chameleonic Behaviour of Macrocyclic Drugs, Chem.Eur. J., 26, 5231, 10.1002/chem.201905599 · DOI · Paper page
- Lee, 2021, Interplay among Conformation, Intramolecular Hydrogen Bonds, and Chameleonicity in the Membrane Permeability and Cyclophilin A Binding of Macrocyclic Peptide Cyclosporin O Derivatives, J. Med. Chem., 64, 8272, 10.1021/acs.jmedchem.1c00211 · DOI
- Bockus, 2015, Going Out on a Limb: Delineating the Effects of β-Branching, N-Methylation, and Side Chain Size on the Passive Permeability, Solubility, and Flexibility of Sanguinamide A Analogues, J. Med. Chem., 58, 7409, 10.1021/acs.jmedchem.5b00919 · DOI · Paper page
- Taechalertpaisarn, 2022, A New Amino Acid for Improving Permeability and Solubility in Macrocyclic Peptides through Side Chain-to-Backbone Hydrogen Bonding, J. Med. Chem., 65, 5072, 10.1021/acs.jmedchem.2c00010 · DOI
- Witek, 2019, Rationalization of the membrane permeability differences in a series of analogue cyclic decapeptides, J. Chem. Inf. Model., 59, 294, 10.1021/acs.jcim.8b00485 · DOI
- Ono, 2019, Conformation and Permeability: Cyclic Hexapeptide Diastereomers, J. Chem. Inf. Model., 59, 2952, 10.1021/acs.jcim.9b00217 · DOI
- Cipcigan, 2021, Membrane Permeability in Cyclic Peptides is Modulated by Core Conformations, J. Chem. Inf. Model., 61, 263, 10.1021/acs.jcim.0c00803 · DOI
- Sugita, 2021, Large-Scale Membrane Permeability Prediction of Cyclic Peptides Crossing a Lipid Bilayer Based on Enhanced Sampling Molecular Dynamics Simulations, J. Chem. Inf. Model., 61, 3681, 10.1021/acs.jcim.1c00380 · DOI
- Sugita, 2022, Lipid Composition Is Critical for Accurate Membrane Permeability Prediction of Cyclic Peptides by Molecular Dynamics Simulations, J. Chem. Inf. Model., 62, 4549, 10.1021/acs.jcim.2c00931 · DOI
- Sugita, 1999, Replica-exchange molecular dynamics method for protein folding, Chem. Phys. Lett., 314, 141, 10.1016/S0009-2614(99)01123-9 · DOI · Paper page
- Wang, 2021, Effect of Flexibility, Lipophilicity, and the Location of Polar Residues on the Passive Membrane Permeability of a Series of Cyclic Decapeptides, J. Med. Chem., 64, 12761, 10.1021/acs.jmedchem.1c00775 · DOI
- Digiesi, 2021, Permeability prediction in the beyond-Rule-of 5 chemical space: Focus on cyclic hexapeptides, Eur. J. Pharm. Biopharm., 165, 259, 10.1016/j.ejpb.2021.05.017 · doi:10.1016/j.ejpb.2021.05.017
- Poongavanam, 2021, Predicting the Permeability of Macrocycles from Conformational Sampling – Limitations of Molecular Flexibility, J. Pharm. Sci., 110, 301, 10.1016/j.xphs.2020.10.052 · DOI
- Hewitt, 2015, Cell-permeable cyclic peptides from synthetic libraries inspired by natural products, J. Am. Chem. Soc., 137, 715, 10.1021/ja508766b · DOI · Paper page
- Zhang, 2012, HELM: A hierarchical notation language for complex biomolecule structure representation, J. Chem. Inf. Model., 52, 2796, 10.1021/ci3001925 · DOI · Paper page
- Rajan, 2021, STOUT: SMILES to IUPAC names using neural machine translation, J. Cheminf., 13, 1, 10.1186/s13321-021-00512-4 · DOI
- Townsend, C. E.; Naylor, M. R.; Jason, E.; Pye, C. R.; Schwochert, J. A.; Edmondson, Q.; Lokey, R. S. The passive permeability landscape around geometrically diverse hexa- and heptapeptide macrocycles. ChemRxiv Preprint, 2020. 10.26434/chemrxiv.13335941.v1. · doi:10.26434/chemrxiv.13335941.v1
Cited by
Revolutionizing peptide‐based drug discovery: Advances in the post‐AlphaFold era
Chang, L., Mondal, A., Singh, B., Martínez‐Noa, Y., & Perez, A. (2024) · WIREs Computational Molecular Science · doi:10.1002/wcms.1693 · Cited by 56
“107 Due to the multiple ways of cyclizing peptides, and the many possible modified amino acids these are not readily implemented in AI tools, but they can be readily parametrized and incorporated into MD pipelines 108 such as the ones previously described.”
MethodMurail, S., Sawmynaden, J., Zemirli, A., Jusot, M., Pietrucci, F., Chomilier, J., Tufféry, P., & Stratmann, D. (2025) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.5c01123 · Cited by 6
Metadata
- Authors
- Li, J., Yanagisawa, K., Sugita, M., Fujie, T., Ohue, M., & Akiyama, Y.
- Venue
- Journal of Chemical Information and Modeling
- Publisher
- American Chemical Society (ACS)
- Published
- 2023-03-17
- Volume
- 63
- Issue
- 7
- Pages
- 2240-2250
- ISSN
- 1549-9596 (ISSN-L)
- 1549-960X
- OpenAlex
- W4327694659
- Cited by
- 91
- References
- 4
- FWCI
- 11.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Funders
- Japan Agency for Medical Research and Development (JP22ama121026)
- Japan Society for the Promotion of Science (20K19917, 22H03684)
- Japan Science and Technology Agency (JPMJFR216J, JPMJSP2106)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.